The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Weaver Gregory L since year 2005.
The trader's CIK number is 1251779.
At the time of this reporting, Weaver Gregory L is the Chief Financial Officer of Eloxx Pharmaceuticals, Inc. .
(stock ticker symbol ELOX).
See this page for all insider trading activities at Eloxx Pharmaceuticals, Inc. .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2018-03-23||ELOX||Eloxx Pharmaceuticals, Inc.||Buy||4,500||8.56||38,520|
|2013-11-21||ATOS||Atossa Genetics Inc||Buy||10,000||2.58||25,790|
|2013-11-20||FCSC||Fibrocell Science, Inc.||Buy||10,000||3.51||35,080|
|2012-12-18||CLSN||Celsion Corp||Option Ex||8,636||2.77||23,921|
|2006-05-25||RNAI||Sirna Therapeutics Inc||Buy||15,000||5.06||75,900|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Weaver Gregory L (Chief Financial Officer of Eloxx Pharmaceuticals, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.